Mersana Therapeutics Inc (MRSN)
3.36
+0.18
(+5.66%)
USD |
NASDAQ |
May 01, 16:00
3.36
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Total Liabilities (Quarterly): 189.16M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 189.16M |
| September 30, 2023 | 210.71M |
| June 30, 2023 | 221.20M |
| March 31, 2023 | 231.90M |
| December 31, 2022 | 242.28M |
| September 30, 2022 | 224.62M |
| June 30, 2022 | 118.32M |
| March 31, 2022 | 117.74M |
| December 31, 2021 | 84.37M |
| September 30, 2021 | 62.04M |
| June 30, 2021 | 58.17M |
| March 31, 2021 | 49.97M |
| December 31, 2020 | 45.31M |
| September 30, 2020 | 36.82M |
| June 30, 2020 | 36.95M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.77M |
| December 31, 2019 | 29.22M |
| September 30, 2019 | 28.61M |
| June 30, 2019 | 30.87M |
| March 31, 2019 | 25.32M |
| December 31, 2018 | 69.71M |
| September 30, 2018 | 64.52M |
| June 30, 2018 | 61.22M |
| March 31, 2018 | 59.21M |
| December 31, 2017 | 60.72M |
| September 30, 2017 | 59.27M |
| June 30, 2017 | 156.87M |
| March 31, 2017 | 63.87M |
| December 31, 2016 | 160.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
28.61M
Minimum
Sep 2019
242.28M
Maximum
Dec 2022
107.95M
Average
62.04M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 617.71M |
| Geron Corp | 146.13M |
| TG Therapeutics Inc | 169.08M |
| Editas Medicine Inc | 150.06M |
| G1 Therapeutics Inc | 86.15M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 226.06M |
| Shareholders Equity (Quarterly) | 36.90M |
| Debt to Equity Ratio | 0.6837 |
| Current Ratio | 3.364 |
| Net Debt Paydown Yield | -0.03% |